Dr. Hahn, who was nominated by President Donald Trump in September, will become commissioner at a time when the FDA faces bipartisan criticism for failing to stop youth vaping.
He was confirmed by a vote of 72-18.
He will take the reins from Ned Sharpless, MD, who has served as acting commissioner since Scott Gottlieb, MD, resigned in April.
A practicing radiation oncologist, Dr. Hahn was most recently CMO of MD Anderson Cancer Center in Houston.
Read the full article here.
More articles on leadership and management:
Pennsylvania hospital CEO resigns amid financial woes, medical service ban
White House’s Dr. Ronny Jackson seeks seat in Congress
Michael Dowling: When it comes to health disparities, gaps in mental health treatment are the worst
